Transmission Dynamics of Carbapenemase Genes in Carbapenem-Resistant Enterobacter cloacae: Insights from Guangdong Teaching Hospitals (2022–2024)

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) represent a critical global health challenge, with Enterobacter cloacae (CREC) ranking among the most prevalent and therapeutically recalcitrant species in China. The COVID-19 pandemic has amplified concerns over antimicrobial resistance (AMR), as increased antibiotic use and altered healthcare workflows may accelerate the emergence and dissemination of multidrug-resistant bacteria. Of particular scientific interest are carbapenemase-encoding genes (CEGs), such as blaNDM-1, blaIMP, and blaKPC-2, which can be rapidly transmitted via mobile genetic elements and lead to pan-resistant infections with limited therapeutic options. Despite ongoing surveillance, the detailed genetic landscape and real-world transmission dynamics of CEGs in CREC—especially during the pandemic—have not been systematically characterized in high-burden regions like Guangdong Province (paper).

Key Innovation from the Reference Study

Chen et al. (2025) provide a comprehensive molecular epidemiological analysis of 54 CREC isolates collected from eight tertiary teaching hospitals in Guangdong between December 2022 and June 2024. The key innovation lies in the integration of plasmid elimination, PCR-based genotyping, and conjugation experiments to unravel both the prevalence and the transmissibility of diverse CEGs during a period of heightened AMR risk. The study quantifies the chromosomal versus plasmid localization of resistance genes and systematically maps the diversity of mobile genetic elements, offering actionable insights for infection control and translational AMR research (paper).

Methods and Experimental Design Insights

The study utilized a rigorous workflow:

• Sodium Dodecyl Sulfate (SDS) plasmid elimination was performed at variable temperatures to distinguish chromosomal from plasmid-borne resistance determinants.
• PCR assays targeted key carbapenemase genes (blaNDM-1, blaIMP, blaKPC-2) and mapped their presence to specific genetic contexts.
• Broth microdilution established phenotypic resistance profiles, benchmarking CEG-positive versus CEG-negative isolates against antimicrobial agents including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin.
• Plasmid conjugation experiments directly quantified horizontal gene transfer rates under laboratory conditions.
• ERIC-PCR and NTSYS software enabled high-resolution genotyping and cluster analysis of strain diversity.
• Mobile genetic elements (MGEs) were characterized, with a focus on ISEcp1, and their co-occurrence patterns were mapped across the CREC population.

This experimental design not only confirms the identity and transmissibility of CEGs, but also contextualizes resistance within genetic and clinical epidemiology (paper).

Protocol Parameters

• assay: Broth microdilution | value_with_unit: standardized CLSI protocol; MIC ranges per antibiotic | applicability: in vitro resistance phenotyping | rationale: Quantifies multidrug resistance patterns in clinical CREC isolates | source_type: paper
• assay: SDS-based plasmid elimination | value_with_unit: variable temperature, optimized per strain | applicability: differentiation of plasmid vs. chromosomal gene locations | rationale: Discriminates mobile from intrinsic resistance determinants | source_type: paper
• assay: Conjugation frequency | value_with_unit: 95.65% transfer success for CEGs | applicability: quantification of horizontal gene transfer | rationale: Establishes transmissibility risk for infection control | source_type: paper
• assay: PCR genotyping | value_with_unit: specific primers for blaNDM-1, blaIMP, blaKPC-2 | applicability: molecular epidemiology | rationale: Defines CEG subtype prevalence and co-occurrence | source_type: paper
• assay: Detection of mobile genetic elements | value_with_unit: prevalence of ISEcp1 at 87.04% | applicability: mapping mobilization capacity | rationale: Identifies dominant vectors of resistance gene spread | source_type: paper
• assay: In vitro/in vivo validation of antimicrobial efficacy | value_with_unit: workflow_recommendation | applicability: translational research on CREC, especially for antimicrobial agent benchmarking | rationale: Supports comparative studies using model agents such as glycylcycline antibiotics | source_type: workflow_recommendation

Core Findings and Why They Matter

Chen et al. report that 85.19% of CREC isolates carried at least one CEG, with blaNDM-1 being the most prevalent. Notably, the blaNDM-1 gene was found on both chromosomes and plasmids in 33.33% of isolates, and exclusively on plasmids in 46.30%, underscoring the critical role of mobile elements in resistance dissemination. The study further identifies that CEG-positive isolates exhibited significantly higher resistance rates to key antibiotics, including imipenem and ceftazidime/avibactam, compared to CEG-negative strains (paper). Plasmid conjugation experiments revealed a striking 95.65% success rate for horizontal transfer of CEGs, particularly for blaNDM-1 and blaIMP, highlighting the potential for rapid inter-strain dissemination within hospital settings. The predominance of the mobile element ISEcp1 (87.04%) and the frequent co-occurrence of multiple MGEs (up to four in 40.74% of isolates) further amplify this risk. Genotypic analysis classified the isolates into 17 distinct clusters, with two dominant genotypes (E and G) widely distributed across hospitals and departments, indicating potential nosocomial spread. The epidemiological data revealed higher detection rates in male and elderly patients, particularly within respiratory medicine departments and from sputum samples. These findings provide granular evidence for the ongoing evolution and hospital-based transmission of multidrug resistance in CREC, with implications for targeted surveillance and infection control policies (paper).

Comparison with Existing Internal Articles

Several internal resources provide context for translational research extending from this molecular epidemiology. For example, "Tigecycline at the Translational Interface" discusses the mechanistic role of Tigecycline—a pioneering glycylcycline antibiotic—in targeting multidrug-resistant pathogens via 30S ribosomal subunit inhibition, a pathway mechanistically orthogonal to carbapenemase-mediated resistance. This complements the findings of Chen et al. by highlighting model agents effective against carbapenemase-carrying strains, such as those described in the Guangdong study. Similarly, "Tigecycline: Glycylcycline Antibiotic Workflows for MDR Bacteria" and "Tigecycline and the Translational Researcher" elaborate on advanced protocols for in vitro and in vivo research using Tigecycline, including infection models relevant to multidrug-resistant Enterobacteriaceae. These resources provide workflow recommendations and troubleshooting strategies directly applicable to the experimental approaches outlined in the reference study.

Limitations and Transferability

While the study offers an advanced snapshot of CEG distribution and mobility in Guangdong, several limitations should be noted:

• Geographic Scope: Findings are drawn from eight teaching hospitals in a single Chinese province; results may not directly extrapolate to other geographical or healthcare settings without validation (paper).
• Genotype-Phenotype Correlation: While resistance genes were robustly identified, comprehensive functional validation (e.g., using in vivo infection models or diverse antimicrobial panels) is an area for future study.
• Temporal Factors: The pandemic context is unique and may not reflect resistance dynamics under routine healthcare operations.
• Potential Detection Bias: The higher detection rates in certain departments or patient demographics may reflect underlying sampling patterns.

Nevertheless, the core methods—especially plasmid elimination, conjugation, and high-resolution genotyping—are broadly transferable to similar AMR surveillance and translational research contexts.

Research Support Resources

For researchers seeking to extend these findings or benchmark novel antimicrobial agents in multidrug-resistant Enterobacteriaceae workflows, validated compounds such as Tigecycline (SKU A5226) are available. Tigecycline, as the first-in-class glycylcycline antibiotic, exhibits potent activity against carbapenemase-producing pathogens, including those harboring resistance determinants characterized in the Guangdong study (source: internal review). APExBIO provides detailed product specifications and application notes to support both in vitro and in vivo modeling of resistance transmission and therapeutic efficacy. These resources are designed to facilitate robust, reproducible workflows for translational AMR research, complementing the molecular epidemiological insights provided by Chen et al. (paper).